EU Industry Benchmark
Pharma
Anonymized security posture data for the pharma sector across the EU. Based on 13787 monitored sites.
46.1
Avg. Score /100
D
Avg. Grade
13787
Sites Tracked
+2.0
vs. EU Average
Critical findings in this industry
9945 of 13787 without HTTPS redirect
9257 of 13787 with unencrypted email (no STARTTLS)
11349 of 13787 without DMARC protection (spoofable)
3430 of 13787 missing 3+ critical security headers
12402 of 13787 without DNSSEC (vulnerable to DNS spoofing)
13517 of 13787 without CAA records (unrestricted certificate issuance)
13734 of 13787 without MTA-STS (email downgrade attacks possible)
Grade Distribution
Security across Europe
Average security score by country — hover for details, click to explore.
/100 · sites
Score by Country
Hosting & Data Residency
52%
EU-headquartered provider
48%
Non-EU provider (CLOUD Act / Schrems II)
Server location via IP geolocation (MaxMind GeoLite2). Company HQ from ASN registry. A site may be physically hosted in the EU but use a US-headquartered provider subject to the CLOUD Act — per Schrems II (CJEU C-311/18), this requires SCCs with supplementary measures. · GDPR Art. 44–49
All data is anonymized. No individual sites are identified. Statistics updated weekly.